Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 672,900 | 646,400 | 901,900 | 278,893 | 266,586 |
| Marketable Securities | 291,700 | 188,200 | 46,700 | 713,698 | 701,039 |
| Receivables | N/A | 1,700 | 13,100 | 1,236 | 27,584 |
| Inventories | 41,500 | 37,100 | 32,000 | 29,184 | 35,589 |
| TOTAL | $1,227,400 | $1,082,700 | $1,247,100 | $1,242,004 | $1,249,874 |
| Non-Current Assets | |||||
| PPE Net | 125,900 | 121,400 | 116,300 | 111,403 | 106,381 |
| Intangibles | 0 | 0 | 0 | 0 | 2,137 |
| Other Non-Current Assets | 397,600 | 392,600 | 370,300 | 359,541 | 331,522 |
| TOTAL | $523,500 | $514,000 | $486,600 | $470,944 | $440,040 |
| Total Assets | $1,750,900 | $1,596,700 | $1,733,700 | $1,712,948 | $1,689,914 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 156,400 | 266,000 | 319,100 | 142,873 | N/A |
| Accounts payable and accrued liabilities | 199,900 | 204,500 | 278,400 | 249,638 | 214,197 |
| Other current liabilities | 1,800 | 7,100 | 12,300 | 23,579 | 33,829 |
| TOTAL | $403,600 | $509,100 | $636,400 | $433,572 | $265,482 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 171,930 | 310,264 |
| Other Non-Current Liabilities | 117,700 | 119,900 | 95,200 | 96,186 | 78,629 |
| TOTAL | $117,700 | $119,900 | $95,200 | $268,116 | $388,893 |
| Total Liabilities | $521,300 | $629,000 | $731,600 | $701,688 | $654,375 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 37 | 37 |
| Retained earnings | 1,229,500 | 967,600 | 1,002,000 | 1,011,223 | 1,035,502 |
| TOTAL | $1,229,600 | $967,700 | $1,002,100 | $1,011,260 | $1,035,539 |
| Total Liabilities And Equity | $1,750,900 | $1,596,700 | $1,733,700 | $1,712,948 | $1,689,914 |